Cancer is a complex disease, of which genesis and development are related to various factors. Focusing on tumor heterogeneity, tumor microenvironment, tumor immunity, early tumor diagnosis, this conference aims to facilitate communication among researchers, and promote cancer therapeutics!
- Cancer Evolution, Cell Plasticity and Cancer Heterogeneity
- Cancer Heterogeneity Driven by CSC
- Chromosome Instability and Cancer Heterogeneity
- Effects of Tumor Microenvironment on Cancer Heterogeneity
- Study of Cancer Metastasis from the View of Cancer Evolution
- Dynamic Monitoring of Cancer Evolution and Heterogeneity
- Cancer Heterogeneity and Molecular Targeted Therapy
- Cancer Driver Gene Detection
- Case Studies of Cancer Evolution and Heterogeneity: Breast Cancer, Colon Cancer and Non-Small Cell Lung Cancer
- Primary and Acquired Drug Resistance
- Single Cell Capture and Sequencing
- Mutated Gene Detection by Digital PCR
- Multi-Omics Analysis
- CTC and cfDNA Liquid Biopsy
- SNP and CNV Analysis
- Tumor Microenvironment and Drug Resistance
- Tumor Microenvironment and Immune Escape
- Regulation of Immunity and Inflammation in Tumor Microenvironment
- Distant Metastasis of Cancer Cells Through Non-Lymphatic Pathways
- Hypoxia, Tumor Microenvironment and Metabolic Reprogramming
- Tumor Microenvironment Targeted and Regulated by Nanotechnology
- Effects of Microenvironment on Immunotherapy
- Treg Cell Heterogeneity and Immunotherapy
- Exosomes and Cancer Immune Tolerance
- Neoantigen-Based Novel Cancer Immunotherapy
- Novel Immune Checkpoints
- Roles of Macrophages in Cancer Immunotherapy
- Individualized Cancer Vaccines
- New Generation Oncolytic Virus Therapy
- CAR- and TCR-T Cell Therapy
- Bispecific Antibody
- Clinical Cases and Strategies of Combination of Cancer Immunotherapies and other Therapies
- TMB and Immunotherapy Efficacy Evaluation
- Big Data Analysis in Cancer Therapeutics
- Proton and Heavy-Ion Therapies of Cancer
- MDT and Comprehensive Prevention & Control of Cancer
- Cancer Biobank
- Oncogene Sequencing
- Laboratory Pathological Testing
- Pathological Imaging and Artificial Intelligence
- Medical Mall
Multiple perspectives will be explored to help understand the complexity of cancer, including evolution, heterogeneity, microenvironment and immunity.
Firms providing the Laboratory Testing will play key roles in early diagnosis on cancerogenesis.
Basic research will be closely combined with clinical application, to improve treatment of cancer.
Researchers from Universities and Institutes
Clinicians from Tumor Department and Other Departments
Personnels from Biological Firms
Dear Mr./Ms.
You have registered successfully, the registration information and attention has been sent to the contact and the participants of the mailbox, please note that check. If not received, please contact the general meeting
